Literature DB >> 29986838

An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition?

Michelle D Tate1, Ashley Mansell2.   

Abstract

Inflammation is an integral aspect of influenza A virus (IAV) infection. It is critical to induce an antiviral environment to reduce viral replication and dissemination, while also being essential to the development and maturation of adaptive immunity, which ultimately resolves infection. Conversely, excessive pulmonary inflammation and cellular influx are characteristic of lethal IAV infections. It has become increasingly apparent that the innate immune inflammasome complex is a crucial moderator in IAV disease pathogenesis. It is responsible for the maturation and secretion of prototypic inflammatory cytokines, Interleukin (IL)-1β and IL-18, and the induction of pyroptotic cell death. This short review will examine recent work on the regulation and targeting of the NLRP3 inflammasome as a means of intrinsic and extrinsic modulation of inflammasome-mediated inflammation. It is encouraging that recent studies suggest 'starving' the inflammasome of substrate, or directly inhibiting activity, may be the means to reducing host inflammatory responses to IAV infection and to directing a positive disease outcome. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29986838     DOI: 10.1016/j.coi.2018.06.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

1.  Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome.

Authors:  Maomao Zhang; Yang Zheng; Yong Sun; Shuang Li; Liangqi Chen; Xiangyuan Jin; Xinyu Hou; Xianglan Liu; Qi Chen; Jing Li; Mingyang Liu; Xianghui Zheng; Yongxiang Zhang; Jian Wu; Bo Yu
Journal:  Theranostics       Date:  2019-05-24       Impact factor: 11.556

2.  A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection.

Authors:  Candice Poux; Aleksandra Dondalska; Joseph Bergenstråhle; Sandra Pålsson; Vanessa Contreras; Claudia Arasa; Peter Järver; Jan Albert; David C Busse; Roger LeGrand; Joakim Lundeberg; John S Tregoning; Anna-Lena Spetz
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

3.  Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.

Authors:  Sarah Rosli; Francis J Kirby; Kate E Lawlor; Kate Rainczuk; Grant R Drummond; Ashley Mansell; Michelle D Tate
Journal:  Br J Pharmacol       Date:  2019-08-19       Impact factor: 8.739

Review 4.  Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity.

Authors:  Sijing Long; Li Yang; Wei Dang; Shuyu Xin; Mingjuan Jiang; Wentao Zhang; Jing Li; Yiwei Wang; Senmiao Zhang; Jianhong Lu
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

5.  Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway.

Authors:  Wen-Ba Wang; Jing-Tao Li; Yi Hui; Jie Shi; Xu-Yan Wang; Shu-Guang Yan
Journal:  Chin Med       Date:  2022-02-05       Impact factor: 5.455

Review 6.  Molecular Mechanisms Underlying the Bioactive Properties of a Ketogenic Diet.

Authors:  Mari Murakami; Paola Tognini
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

Review 7.  Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.

Authors:  Brianna J Stubbs; Andrew P Koutnik; Emily L Goldberg; Vaibhav Upadhyay; Peter J Turnbaugh; Eric Verdin; John C Newman
Journal:  Med (N Y)       Date:  2020-07-15

Review 8.  Die Another Way: Interplay between Influenza A Virus, Inflammation and Cell Death.

Authors:  Gabriel Laghlali; Kate E Lawlor; Michelle D Tate
Journal:  Viruses       Date:  2020-04-04       Impact factor: 5.048

Review 9.  Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome.

Authors:  Dacquin M Kasumba; Nathalie Grandvaux
Journal:  Trends Pharmacol Sci       Date:  2018-12-31       Impact factor: 14.819

10.  Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A.

Authors:  Yan Zhao; Chao Yu; Wei Ni; Hua Shen; Mengqi Qiu; Youyun Zhao
Journal:  J Clin Lab Anal       Date:  2020-11-22       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.